TABLE 3—
No.a | Range of Levels (Untransformed)b | Mean Level (SD) (Untransformed) | Multiplicative Increase (95% CI)c | |
Total NNAL (pmol/mL) | ||||
Protected workers (reference) | 31 | 0.01–0.18 | 0.02 (0.03) | 1.00 |
Exposed workers | 50 | 0.01–0.31 | 0.04 (0.05) | 2.85d (1.77, 4.60)** |
Total nicotine (ng/mL) | ||||
Protected workers (reference) | 32 | 1.00–7.22 | 1.39 (1.33) | 1.00 |
Exposed workers | 52 | 1.00–319.00 | 44.36 (61.25) | 15.12 (8.37, 27.33)** |
Total cotinine (ng/mL) | ||||
Protected workers (reference) | 32 | 1.00–5.35 | 1.4 (0.99) | 1.00 |
Exposed workers | 52 | 1.00–72.80 | 20.20 (18.27) | 10.52 (6.90, 16.04)** |
Notes. NNAL = 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol; SD = standard deviation; CI = confidence interval.
aTotal NNAL (pmol/mL) could not be determined in 3 participants’ urine samples.
bA value of half the limit of detection was used for nondetectable values. Limit of detection: cotinine, 2 ng/mL; nicotine, 2 ng/mL; NNAL, 0.007–0.01 pmol/mL depending on recovery.
cBy exposure status. Multiplicative increase was based on linear regression and adjusted for participant age, gender, and exposure to secondhand smoke outside the workplace.
dInterpretation: Being exposed to workplace secondhand smoke was significantly associated with an almost 300 percent increase in the level of total urinary NNAL.
** P < .001.